Oncotarget

Thymol reduces inflammation in the uterus caused by bacterial toxins by controlling immune and stress-related signaling pathways

Updated

Abstract

Thymol markedly alleviated LPS-induced pathological injury and inflammation in mouse endometritis.

  • Thymol reduced myeloperoxidase activity and the production of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in vivo.
  • In vitro studies showed that thymol inhibited the expression of TNF-α, IL-1β, inducible nitric oxide synthase, and cyclooxygenase-2 in a dose-dependent manner.
  • Thymol treatment inhibited the expression of the Toll-like receptor 4-mediated nuclear factor-κB pathway.
  • Silencing of TLR4 blocked the activation of the NF-κB pathway.
  • Thymol also reduced LPS-induced reactive oxygen species production in a dose-dependent manner.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free